Early versus late treatment of voiding dysfunction with pelvic neuromodulation

Authors

  • Magdy M. Hassouna Division of Urology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ont.
  • Mohamed S. Elkelini Division of Urology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ont.

DOI:

https://doi.org/10.5489/cuaj.52

Abstract

Introduction: Pelvic neuromodulation is an established method of treating voidingdysfunction. Little is known about the pathophysiology associated with voiding dysfunction. Reports have suggested that a delay in treating patients with sacral neuromodulation therapy can impact the success rate of this type oftreatment in voiding dysfunction. We examined patient response to pelvic neuromodulationwhen it was applied early versus late in the postdiagnosis of voidingdysfunction.

Methods: We conducted a retrospective study of 42 patients (38 women and4 men) with voiding dysfunction who underwent surgery for implant with the Interstim (Medtronic, Minneapolis, Minn.). Prior to implantation, patients wererequired to pass a percutaneous nerve evaluation (PNE) over a 1-week period. Patients were observed for 20–48 months postimplantation. All patients recorded their voiding parameters at baseline, after screening and every 6 months thereafter. Twenty patients (in the early group) underwent implant surgery withthe neurostimulator 2–4 weeks post-PNE, and 22 patients (the late group)had the device implanted 6–24 months post-PNE owing to local logisticalcircumstances.

Results: In the early group, 16 of 20 patients (80%) maintained a good response.In the late group, 13 of 22 (59%) patients showed a good response. Groupswere well matched in terms of age, duration of voiding dysfunction and incidenceof comorbidity.

Conclusion: Patients who were delayed more than 6 months in receiving the neurostimulatorimplant showed a worse response than did patients who had thedevice implanted soon after PNE. This indicates the possibility of disease progression,which may limit the response to sacral neuromodulation.

Downloads

Download data is not yet available.

Downloads

Published

2012-12-10

How to Cite

Hassouna, M. M., & Elkelini, M. S. (2012). Early versus late treatment of voiding dysfunction with pelvic neuromodulation. Canadian Urological Association Journal, 1(2). https://doi.org/10.5489/cuaj.52

Issue

Vol. 1 No. 2 (2007): CUAJ June

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.